INTRODUCTION
The cyclopentenone prostanoids are derived prostaglandin D 2 , the latter being a byproduct of the metabolism of arachidonic acid in inflammation. The cyclopentenone core play several biological activities, namely: anti-inflammatory, anticancer and antiviral. Due to the biological importance of this structural motif, we began a research project aimed at synthesizing some potentially anti-inflammatory cyclopentenone derivatives using a Morita-BaylisHillman adduct as substrate. So, we described herein a new approach for the construction of substituted cyclopentenone derivatives. These cyclopentenones present in their structures some requirements to deliver anti-inflammatory activity.
RESULTS AND DISCUSSION
Our approach for the synthesis of our target cyclopentenones 1 is based on a rhodium-catalyzed 1,4-addition 2 between a Morita-Baylis-Hillman adduct 3 and a suitable substituted boronate 4 , using a protocol described by Gênet et al (Sheme 1). Reagents and conditions: a) [Rh(cod)Cl]2 1-2 mol%; toluene/methanol ; reflux 3-8h; b) DIBAL-H; CH2Cl2; -78°C; 1h; c) CBr4; PPh3; CH2Cl2; 0°C -r.t.; 2h; d) Ethyl malonate, NaH; THF; 0°C; e) NaCl; H2O; DMSO; reflux 18h; f) Ethanol; NaOH 2N; reflux 3h; g) i. DMF; CH2Cl2; (COCl)2; 0°C -r.t.; 1h; ii. AlCl3; HCl 1N; 0°C -r.t.; 2h;
Scheme 1. Preparation of target cyclopentenones from Morita-Baylis-Hillman adducts
This reaction affords α-substituted cinnamate derivatives, in moderate to good yield and high Eselectivity.
These derivatives were readily transformed into allylic bromides in two steps. The C2 homologation we need to prepare our 5-membered ring was made using a classical approach. So, the allylic bromides prepared above were used as alkylating agent in a reaction with ethyl malonate, in the presence of NaH. After decarboxylation and hydrolysis the resulting γ-unsaturated acid was used in an intramolecular Friedel-Crafts alkylation to afford the required substituted cyclopentenones, in 8 steps and 31% (R = F), 14% (R = SO2CH3) and 10% (R = SO2NH2) overall yield (Scheme 1).
CONCLUSION
This approach has allowed the synthesis of cyclopentenone derivatives 14-16 in 8 steps. At present the anti-inflammatory activity of these cyclopentenones is under evaluation in experimental models of allergic inflammation and non-allergic by observing the effectiveness of this molecule on the hallmarks of inflammation, namely edema, cell migration, excessive mucus production, and bronchial hyperreactivity chemical mediators.
